Comics for Education
The CDC PEPFAR TB HIV Care Biobehavioural Study of people who inject drugs 2023
Conducted in South Africa at four sites in 2023 between May and September, TB HIV Care’s BioBehavioural Survey (BBS) showed high prevalence rates of HIV and Hepatitis C in people who inject drugs (PWID). The Survey found that HIV prevalence among PWID was as high as 72.1% in Tshwane, 49.3% in eThekwini, 45.4% in Mashishing, and 30.3% in Mbombela. Anti-hepatitis C prevalence was highest in Mbombela (90.5%), followed by Tshwane (89.0%), eThekwini (75.2%), and Mashishing (40.8%). The Survey also measured the prevalence of drug-susceptible tuberculosis (TB) in the study population, generating the first such data in South Africa. Across the sites statistics pointed to a notable burden and the need for intensified TB diagnosis and treatment by highlighting prevalence of 7.2% in eThekwini, 2% in Tshwane and less than 1% in both the Mashishing and Mbombela sites.
|
Data on South African of key drug policy & harm reduction indicators.
In 2021 and 2022, as a partner in the Love Alliance, SANPUD partnered with Mainline as a resource partner and tasked Mainline to develop a database with relevant information about drug use, harm reduction and drug policy in all the 10 Love Alliance priority countries.
Drug information and resources
We don't want to reinvent the wheel. There are many good sites that provide excellent and reliable information about drugs. We have included links to some of our favourite examples.
Drug Mixing Chart by TRIPSIT
WARNING! For educational purposes: We do not endorse any of these combinations. This page will always be 'work in progress'. It is extremely important to be safe at all times! Click here for further details and information from the creators of this matrix.
WARNING! For educational purposes: We do not endorse any of these combinations. This page will always be 'work in progress'. It is extremely important to be safe at all times! See here for more.
Video Resources
SANPUD related video resources, including interviews and podcasts with the founding members on general drug-related areas.
|
|
|
|
|
|